Treating Inflammatory Conditions With Biosimilars: A Managed Care Update of Real-World Evidence and Cost-Savings Data
This live activity will identify the patient populations with rheumatic and inflammatory disease and consider the biologic costs associated with pharmacologic treatment.
Use of Oncology Supportive Care Biosimilars During COVID-19: Clinical Strategies for Pharmacists
This activity will provide pharmacists with an overview of growth factor biosimilars, with an emphasis on use for neutropenia and alternative approaches during the pandemic.
Incorporating the Use of Biosimilars into Clinical Practice: Opportunities for Pharmacists to Intervene
This activity will review the approval process and required nomenclature for biosimilars as well as the differences between biosimilars and biologics.
Increasing Access to Diabetes Care Through Insulin Biosimilars
This activity will highlight direct and indirect costs of diabetes in the United States today and the potential effects of and barriers to biosimilar insulin.